Syros Pharmaceuticals Stock Price on September 3, 2024
| SYRS Stock | USD 0.27 0.02 8.00% |
Below is the normalized historical share price chart for Syros Pharmaceuticals extending back to June 30, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Syros Pharmaceuticals stands at 0.27, as last reported on the 28th of November, with the highest price reaching 0.28 and the lowest price hitting 0.25 during the day.
If you're considering investing in Syros Stock, it is important to understand the factors that can impact its price. Syros Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.039, which indicates the firm had a -0.039% return per unit of risk over the last 3 months. Syros Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Syros Pharmaceuticals' Risk Adjusted Performance of (0.02), variance of 207.37, and Coefficient Of Variation of (2,967) to confirm the risk estimate we provide.
At this time, Syros Pharmaceuticals' Common Stock Total Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 29.7 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 147.5 M in 2024. . At this time, Syros Pharmaceuticals' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 13.91 in 2024, whereas Price Earnings Ratio is likely to drop (1.41) in 2024. Syros Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 30th of June 2016 | 200 Day MA 4.2436 | 50 Day MA 1.7853 | Beta 1.592 |
Syros |
Sharpe Ratio = -0.039
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SYRS |
Estimated Market Risk
| 14.61 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.57 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Syros Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Syros Pharmaceuticals by adding Syros Pharmaceuticals to a well-diversified portfolio.
Price Book 10.6509 | Enterprise Value Ebitda (0.41) | Price Sales 18.5951 | Shares Float 13.9 M | Wall Street Target Price 1 |
Related Headline
Larimar Therapeutics Headline on 3rd of September 2024
Larimar Therapeutics initiated with an Outperform at Baird -... by news.google.com
Larimar Therapeutics initiated with an Outperform at Baird TipRanks
Syros Pharmaceuticals Valuation on September 3, 2024
It is possible to determine the worth of Syros Pharmaceuticals on a given historical date. On September 3, 2024 Syros was worth 1.6 at the beginning of the trading date compared to the closed value of 1.55. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Syros Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Syros Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Syros Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Syros Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 1.69 | 1.69 | 1.61 | 1.64 | 113,163 | |
09/03/2024 | 1.60 | 1.69 | 1.55 | 1.55 | 110,284 |
| 1.54 | 1.57 | 1.50 | 1.53 | 112,489 |
| Backtest Syros Pharmaceuticals | | | Syros Pharmaceuticals History | | | Syros Pharmaceuticals Valuation | Previous | Next |
Syros Pharmaceuticals Trading Date Momentum on September 3, 2024
| On September 04 2024 Syros Pharmaceuticals was traded for 1.53 at the closing time. The top price for the day was 1.57 and the lowest listed price was 1.50 . The trading volume for the day was 112.5 K. The trading history from September 4, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 1.29% . The trading price change against the current closing price is 15.48% . |
Syros Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Syros Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Syros Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Syros financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Syros Pharmaceuticals Stock history
Syros Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Syros is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Syros Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Syros Pharmaceuticals stock prices may prove useful in developing a viable investing in Syros Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 28.3 M | 29.7 M | |
| Net Loss | -85.2 M | -89.4 M |
Syros Pharmaceuticals Quarterly Net Working Capital |
|
Syros Pharmaceuticals Stock Technical Analysis
Syros Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Syros Pharmaceuticals Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Syros Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Syros Pharmaceuticals November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Syros Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Syros Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Syros Pharmaceuticals stock market strength indicators, traders can identify Syros Pharmaceuticals entry and exit signals to maximize returns
Syros Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Syros Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Syros Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Syros to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (2.66) | |||
| Treynor Ratio | (0.62) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Syros Stock Analysis
When running Syros Pharmaceuticals' price analysis, check to measure Syros Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syros Pharmaceuticals is operating at the current time. Most of Syros Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syros Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syros Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syros Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.